While human GYPB is well-characterized as a receptor for Plasmodium falciparum during erythrocyte invasion , the recombinant chimpanzee variant is primarily used to study:
Evolutionary Conservation: Comparative analyses reveal conserved motifs in the extracellular domain critical for pathogen interactions .
Antigen Presentation: The protein’s sialic acid residues and glycosylation patterns influence antigenicity, particularly in the Ss blood group system .
Chimpanzee GYPB is used to investigate cross-species interactions with Plasmodium parasites. For example:
Receptor Binding: Recombinant GYPB binds to P. falciparum ligands (e.g., EBL-1), aiding in understanding host-parasite co-evolution .
Variant Phenotypes: Hybrid GYPB alleles (e.g., GYPB-E-B) are studied to identify protective traits against malaria .
Ss Antigen Presentation: The S antigen (MNS4) on GYPB is critical for blood typing. Recombinant GYPB helps map antigenic epitopes and hybrid variants (e.g., GP.Mur, GP.Bun) .
Gene Conversion: The high homology between GYPA and GYPB facilitates gene conversion events, studied using recombinant proteins .
| Supplier | Catalog Number | Expression System | Species Reactivity | Tag/Conjugation |
|---|---|---|---|---|
| MyBioSource | MBS7016488 | Cell-Free | Chimpanzee | Not specified |
| Cusabio | CSB-CF631735EQV | E. coli | Chimpanzee | Biotinylation |
| Domain | Human GYPB | Chimpanzee GYPB |
|---|---|---|
| Extracellular | Sialic acid-rich motifs | Conserved sialic acid motifs |
| Transmembrane | Hydrophobic residues | Identical hydrophobic residues |
This protein is a minor sialoglycoprotein found in erythrocyte membranes.
Glycophorin-B is a major sialoglycoprotein expressed on the erythrocyte (red blood cell) membrane surface. In chimpanzees (Pan troglodytes), as in humans, GYPB functions as part of the erythrocyte membrane protein complex. GYPB is also known by alternative names including PAS-3, SS-active sialoglycoprotein, and sialoglycoprotein delta . The protein is significant in comparative primate research as it exists in chimpanzees, pygmy chimpanzees (bonobos), and gorillas, but is notably absent in orangutans and gibbons . Studies have shown that GYPB interacts with other membrane proteins including the Rhesus (Rh) protein subcomplex, which consists of RhCe, RhD, and Rh-associated glycoprotein (RhAG), along with CD47, LW protein, and other membrane components .
There are significant structural differences between chimpanzee and human GYPB. While both share high sequence similarity in the extracellular domain and transmembrane regions, evolutionary analysis reveals species-specific adaptations. The human GYPB gene has undergone unique evolutionary changes, including the ability to encode both Glycophorin-C and Glycophorin-D (GPC and GPD) from a single transcript through the use of two translation start codons – a feature that is absent in chimpanzee GYPB .
The amino acid sequence of human GYPB includes the region LSTTEVAMHTSTSSSVTKSYISSQTNGETGQLVHRFTVPAPVVIILIILCVMAGIIGTILLISYSIRRLIKA, which corresponds to positions 20-91 of the full-length protein . Comparative analysis of this region with the chimpanzee homolog reveals evolutionary divergence patterns that likely reflect different selective pressures between the species.
Evolutionary analysis indicates that the GYPB gene arose from an ancestral Glycophorin-A (GPA) gene through gene duplication events that occurred during primate evolution, prior to the divergence of gorillas from the human-chimpanzee lineage approximately a15 million years ago. Research has established that while the GPA gene is present across all studied primates, the GYPB gene specifically appeared in the evolutionary timeline after orangutans and gibbons diverged from the lineage, but before gorillas branched off .
The genomic evidence suggests that GYPB arose through homologous recombination at Alu repetitive sequences during or after gene duplication from an ancestral GPA-like gene . This recombination event resulted in the acquisition of 3' sequences different from those of the GPA gene, contributing to the functional differentiation between these two glycophorins .
For optimal expression and purification of recombinant chimpanzee GYPB, researchers should implement a comprehensive approach combining molecular cloning techniques with advanced protein purification methods. Based on established protocols for human GYPB, the following methodology is recommended:
Optimized Expression Protocol:
Design expression vectors containing the chimpanzee GYPB coding sequence (focusing on the extracellular domain, positions equivalent to human GYPB 20-91) with appropriate affinity tags
Express the protein in a eukaryotic expression system (preferably HEK293 or CHO cells) to ensure proper glycosylation patterns
Culture cells in serum-free media supplemented with essential glycosylation precursors to maintain native-like post-translational modifications
Purification Strategy:
Initial capture using immobilized metal affinity chromatography (IMAC)
Secondary purification via ion exchange chromatography to separate variant glycoforms
Final polishing step utilizing size exclusion chromatography
The recombinant protein should be stored in Tris-based buffer with 50% glycerol at -20°C for short-term storage or -80°C for extended storage, avoiding repeated freeze-thaw cycles . For working aliquots, storage at 4°C for up to one week is acceptable .
The evolutionary trajectory of GYPB differs significantly between chimpanzees and humans, revealing distinct selective pressures. Molecular evolution studies have identified that while the genes for GPA and GYPB are homologous from the 5'-flanking region to approximately 1 kilobase downstream from the exon encoding the transmembrane region, they diverge significantly in their 3' sequences .
Analysis of sequence data reveals:
| Species | GYPB Status | Evidence of Selection | Associated Functional Changes |
|---|---|---|---|
| Human | Present | Accelerated evolution, possible positive selection | Development of dual GPC/GPD encoding capability; adaptation to malaria pressures |
| Chimpanzee | Present | Different pattern of selection than humans | Maintained ancestral function without the dual encoding feature |
| Gorilla | Present (in only 7 of 16 studied) | Possible transitional evolutionary state | 24-bp insertion in transmembrane exon derived from ancestral GPB gene |
| Orangutan | Absent | N/A | Relies solely on GPA for similar functions |
| Gibbon | Absent | N/A | Relies solely on GPA for similar functions |
The evolutionary patterns suggest that GYPB in humans has undergone adaptation potentially related to malaria resistance, as glycophorins serve as receptors for Plasmodium falciparum parasites . The chimpanzee GYPB, while sharing homology, appears to have experienced different selective pressures, potentially reflecting differences in pathogen exposure or functional requirements of the erythrocyte membrane between the species .
Gene conversion events between the three glycophorin genes (GPA, GYPB, and GYPE) in chimpanzees have significant implications for functional studies, particularly when examining receptor-ligand interactions and evolutionary adaptations.
The high sequence similarity (>95%) between these genes has facilitated frequent gene conversion events, which have contributed to their molecular evolution . These events introduce sequence variations that can be classified as either "gene-specific" or "shared" changes:
Gene-specific changes: Unique derived mutations not shared with paralogs
Shared changes: Derived mutations identical to nucleotides found in one or both paralogs at the same position, likely introduced by gene conversion
Research indicates that gene conversion has contributed significantly to the nucleotide diversity observed in these genes across primates . For functional studies, researchers must consider that:
Experimental designs must account for potential chimeric sequences resulting from gene conversion
Expression constructs should be carefully validated to ensure they represent authentic chimpanzee sequences rather than conversion products
Functional assays comparing human and chimpanzee glycophorins must control for gene conversion effects to accurately attribute phenotypic differences to species-specific adaptations rather than conversion artifacts
Given the high sequence similarity (>95%) among glycophorin genes, accurate amplification and characterization of chimpanzee GYPB requires sophisticated PCR and sequencing strategies to avoid cross-amplification and ensure paralog-specific analysis.
Recommended PCR Strategy:
Design long-range PCR primers targeting unique flanking regions of GYPB to amplify the complete gene
Utilize high-fidelity DNA polymerase systems that provide exceptional accuracy and can amplify long templates
Implement nested PCR approaches for increased specificity
Optimized PCR Conditions:
Reaction mixture: 1× PCR buffer, 2 mM MgSO₄, 1 unit Platinum Taq DNA polymerase High Fidelity, 200 μM dNTP, 0.2 μM of each primer, and 50 ng genomic DNA (final volume 25 μl)
Thermal cycling: Initial denaturation (94°C for 1 min), followed by 35 cycles of amplification (95°C for 30s, 58°C for 30s, 68°C for 6 min 30s), and final extension (72°C for 5 min)
Sequencing Approach:
Prepare PCR products for sequencing using alkaline phosphatase and exonuclease I treatment
Implement bidirectional sequencing with internal primers designed to unique regions
Utilize automated sequence analysis (such as ABI 3730XL) and assemble contigs with specialized software like Sequencher 4.8 for identification of heterozygous sites
Verification Steps:
Confirm paralog specificity through phylogenetic analysis comparing the obtained sequences with reference sequences from GPA, GYPB, and GYPE
Validate results with restriction fragment length polymorphism (RFLP) analysis using paralog-specific restriction sites
To effectively compare the receptor properties of recombinant human versus chimpanzee GYPB, researchers should implement a multi-faceted functional binding assay approach that controls for structural and post-translational differences:
Comparative Binding Assay Design:
Expression System Selection:
Utilize identical expression systems (preferably mammalian) for both human and chimpanzee GYPB to ensure comparable post-translational modifications
Express both proteins with identical affinity tags in the same position to prevent tag-related binding artifacts
Binding Partner Panel:
Test binding against a diverse panel of potential ligands including:
Plasmodium falciparum erythrocyte binding antigens (EBA family proteins)
Membrane-associated proteins known to interact with glycophorins
Antibodies targeting conserved and variable epitopes
Methodological Approaches:
| Assay Type | Methodology | Measured Parameters | Advantages |
|---|---|---|---|
| Surface Plasmon Resonance | Immobilize recombinant GYPB on sensor chip; flow potential binding partners | Association/dissociation rates, binding affinity (KD) | Real-time kinetics, label-free detection |
| Bio-Layer Interferometry | Immobilize GYPB on biosensor tips; dip into ligand solutions | Binding kinetics, concentration dependence | Higher throughput than SPR |
| Cell-Based Binding | Express GYPB on cell surface; incubate with fluorescently-labeled ligands | Cell-surface binding, internalization | Maintains native membrane environment |
| Pull-Down Assays | Immobilize recombinant GYPB; incubate with cell lysates or purified proteins | Binding partners, complex formation | Identifies novel interaction partners |
Controls and Validation:
Include chimeric constructs with swapped domains between human and chimpanzee GYPB to map interaction sites
Implement site-directed mutagenesis to evaluate the impact of species-specific amino acid differences
Validate binding results with complementary techniques such as crosslinking studies and co-immunoprecipitation
This comprehensive approach will allow researchers to identify both quantitative differences in binding affinities and qualitative differences in binding partner specificity between human and chimpanzee GYPB.
When analyzing how GYPB sequence variations between humans and chimpanzees affect malaria parasite invasion, researchers must address several critical considerations:
Key Experimental Design Considerations:
Parasite Strain Selection:
Include diverse Plasmodium falciparum strains with different invasion pathways
Consider geographic origin of strains relative to historical chimpanzee and human populations
Include laboratory-adapted strains and recent clinical isolates for comprehensive assessment
Erythrocyte Model Systems:
Develop transgenic erythrocyte precursors expressing either human or chimpanzee GYPB
Control for expression level differences that might affect invasion efficiency
Account for interactions with other erythrocyte membrane proteins that differ between species
Invasion Assay Optimization:
Standardize parasite inoculum across experiments
Utilize flow cytometry with multiple markers to distinguish invasion stages
Implement time-lapse microscopy to capture kinetic differences in invasion
Molecular Determinants Analysis:
Focus on extracellular domain variations, particularly in regions containing:
N-glycosylation sites that differ between species
O-glycosylation patterns that may affect receptor recognition
Amino acid substitutions in predicted binding interfaces
Research has demonstrated that glycophorins function as major receptors for Plasmodium falciparum on erythrocyte surfaces . The evolutionary patterns observed in these genes, including evidence for balancing selection in humans, likely reflect adaptations to malaria exposure . When comparing human and chimpanzee GYPB, researchers should particularly focus on the extracellular domains that interact with parasite ligands, as these regions show evidence of adaptive evolution.
To effectively study membrane complex interactions of GYPB in chimpanzee erythrocytes compared to human samples, researchers should employ a combination of biochemical, biophysical, and advanced imaging approaches:
Recommended Technical Approaches:
Membrane Protein Complex Isolation:
Optimize detergent solubilization conditions specifically for chimpanzee erythrocyte membranes
Implement blue native PAGE to preserve native protein complexes
Use chemical crosslinking prior to solubilization to stabilize transient interactions
Interaction Mapping:
Apply proximity labeling techniques (BioID or APEX2) fused to GYPB to identify neighboring proteins
Utilize co-immunoprecipitation with antibodies recognizing conserved epitopes
Implement comparative quantitative proteomics to identify species-specific interaction partners
Structural Characterization:
Use cryo-electron microscopy to analyze protein complexes containing GYPB
Apply hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
Implement super-resolution microscopy to visualize distribution and clustering
Functional Assessment:
Analyze membrane stability through osmotic fragility testing
Measure lateral diffusion rates using fluorescence recovery after photobleaching (FRAP)
Assess cytoskeletal interactions through atomic force microscopy
Research has shown that GYPB interacts with the Rhesus (Rh) protein complex (including RhCe, RhD, and RhAG) along with other membrane proteins including CD47 and LW protein . Comparative studies between species must account for potential differences in these interaction partners as well as in the GYPB protein itself. For example, the stability of the Rh protein subcomplex is known to be affected by cytoskeletal adaptor proteins like ankyrin, which influences membrane protein retention during erythrocyte maturation .
Chimpanzee GYPB offers a valuable model for studying the evolution of pathogen resistance mechanisms in primates, particularly when examined in the broader context of glycophorin evolution:
Research Applications and Approaches:
Comparative Susceptibility Studies:
Engineer erythrocyte precursor cell lines expressing either human or chimpanzee GYPB
Challenge with various pathogen proteins known to interact with glycophorins
Analyze differential binding, invasion efficiency, and cellular responses
Evolutionary Reconstruction Analysis:
Utilize ancestral sequence reconstruction to synthesize presumed ancestral GYPB variants
Test functional properties of ancestral variants against modern human and chimpanzee versions
Map the emergence of resistance-conferring mutations along the primate phylogenetic tree
Population Genetics Framework:
Compare patterns of nucleotide diversity in GYPB between human and chimpanzee populations
Identify signatures of selection (balancing, positive, purifying) across the gene
Correlate selection patterns with historical pathogen exposure in different primate populations
Glycophorins serve as major receptors for Plasmodium falciparum on erythrocyte surfaces, making them central to malaria pathology . Research has revealed divergent patterns of genetic variation between glycophorin genes and between different extracellular domains, with evidence of fixed adaptive changes in certain regions .
The presence of GYPB in chimpanzees, pygmy chimpanzees, and gorillas, but not in orangutans and gibbons, suggests that its emergence and subsequent evolution correlate with specific pathogen pressures after evolutionary divergence from orangutans . By comparing human and chimpanzee GYPB variants, researchers can identify specific molecular adaptations that evolved in response to species-specific pathogen challenges.
The 24-base pair insertion sequence in the transmembrane exon of GYPE has significant implications for comparative structural biology studies involving chimpanzees:
Structural and Functional Implications:
Membrane Topology Effects:
The insertion likely alters the positioning of the transmembrane domain within the lipid bilayer
This may affect interaction with membrane-spanning proteins in the glycophorin complex
Changes in membrane topology could influence signal transduction capabilities
Evolutionary Context:
The insertion sequence was derived from the ancestral GPB gene and inserted into the ancestral GPE gene prior to gorilla divergence
This represents a significant evolutionary event that predates human-chimpanzee divergence
The insertion appears to be fixed in chimpanzees but shows polymorphism in gorillas (present in only 7 of 16 studied)
Methodological Considerations for Structural Studies:
Protein modeling must account for the additional 8 amino acids in the transmembrane domain
Membrane mimetics (detergents, nanodiscs, lipid bilayers) must be optimized for the extended transmembrane region
Structural techniques including NMR and cryo-EM need specific adaptation for the altered hydrophobic region
Functional Hypotheses:
The insertion may confer resistance to specific pathogens that target this region
It could alter membrane fluidity or curvature in the microenvironment of the protein
The extended transmembrane domain might influence protein clustering or segregation in membrane microdomains
This insertion represents a fascinating example of how gene conversion and recombination events contribute to functional innovation in membrane proteins . For comparative structural biology studies, researchers must account for how this insertion affects not only the structure of GYPE itself but also its interactions within the broader membrane protein complex.
Distinguishing between gene conversion and parallel mutation in chimpanzee Glycophorin-B evolution requires sophisticated analytical approaches that combine molecular genetics, phylogenetics, and statistical models:
Methodological Framework:
Sequence Pattern Analysis:
Identify shared derived mutations between GYPB and its paralogs (GPA, GYPE)
Map the distribution of these shared changes along the gene sequence
Gene conversion typically produces clusters of shared changes, while parallel mutations occur independently
Statistical Testing:
Haplotype Structure Examination:
Analyze linkage disequilibrium patterns within and between glycophorin genes
Identify recombination hotspots that may facilitate gene conversion
Examine the boundaries of shared haplotype blocks for evidence of conversion tract boundaries
Phylogenetic Approaches:
Construct gene trees for small windows across the glycophorin genes
Identify regions where tree topology shifts in ways consistent with gene conversion
Apply phylogenetic network methods to visualize reticulate evolution
The analysis of glycophorin genes is complicated by their high sequence similarity (>95%), which facilitates frequent gene conversion . When examining chimpanzee GYPB evolution, researchers should specifically focus on:
The transition sites from homologous to nonhomologous sequences within Alu repeat regions, which mark recombination events during gene duplication
The patterns of genetic differentiation between paralogous genes using Nei's D<sub>xy</sub> estimate to calculate fixed differences with Jukes-Cantor correction
The population recombination parameter (4Nr) that quantifies recombination frequency within these genes
By applying this comprehensive framework, researchers can distinguish the molecular mechanisms driving GYPB evolution in chimpanzees and accurately reconstruct its evolutionary history.
The comparative study of recombinant chimpanzee and human GYPB presents several promising research directions that could enhance our understanding of erythrocyte membrane biology, pathogen interactions, and primate evolution:
High-Priority Research Directions:
CRISPR-Based Functional Studies:
Generate isogenic cell lines with species-specific GYPB variants
Create chimeric GYPB proteins with domains swapped between species
Assess functional consequences of specific evolutionary changes
Structural Biology Initiatives:
Determine high-resolution structures of both human and chimpanzee GYPB
Map species-specific differences in glycosylation patterns
Characterize membrane protein complex architecture differences
Pathogen Interaction Landscapes:
Screen diverse pathogens (viral, bacterial, parasitic) for differential binding to human versus chimpanzee GYPB
Identify novel pathogen interactions that may have driven species-specific adaptations
Reconstruct evolutionary arms races between pathogens and primate hosts
Translational Applications:
Develop therapeutic candidates based on species-specific resistance mechanisms
Design diagnostic tools leveraging evolutionary insights from comparative glycophorin biology
Create enhanced cell culture systems incorporating optimized glycophorin variants
The evolutionary history of GYPB, with its emergence before gorilla divergence but after orangutan divergence , positions comparative studies between humans and chimpanzees at a critical evolutionary juncture. The evidence for gene conversion, adaptive evolution, and structural innovation in these genes suggests that continued research will yield important insights into how membrane protein evolution contributes to species-specific traits and disease susceptibility patterns.
Despite advances in recombinant protein technology, several methodological challenges persist in the production and characterization of recombinant chimpanzee GYPB:
Current Challenges and Proposed Solutions:
Post-Translational Modification Fidelity:
Challenge: Ensuring proper glycosylation patterns matching native chimpanzee GYPB
Solution: Develop chimpanzee cell lines or engineer human cell lines to express chimpanzee-specific glycosyltransferases; implement glycoengineering approaches to control glycoform profiles
Membrane Protein Solubility:
Challenge: Maintaining proper folding and solubility of the transmembrane region
Solution: Optimize detergent screening protocols; employ novel amphipathic polymers; develop nanodiscs with species-appropriate lipid compositions
Functional Validation:
Challenge: Confirming that recombinant GYPB exhibits native-like properties
Solution: Establish erythrocyte membrane integration assays; develop comprehensive binding partner validation panels; implement activity-based protein profiling
Structural Analysis:
Challenge: Obtaining structural information for flexible, glycosylated membrane proteins
Solution: Combine complementary approaches (cryo-EM, NMR, X-ray crystallography); utilize molecular dynamics simulations to model flexible regions; implement hydrogen-deuterium exchange mass spectrometry for dynamics studies
Species-Specific Reagents:
Challenge: Limited availability of chimpanzee-specific antibodies and validation tools
Solution: Develop cross-reactive monoclonal antibodies targeting conserved epitopes; implement phage display to generate species-specific binding reagents; create validated peptide standards for mass spectrometry
Addressing these challenges will require interdisciplinary approaches combining glycobiology, membrane protein biochemistry, and comparative genomics. Researchers should consider implementing cutting-edge technologies such as machine learning-based protein design and advanced glycoproteomics to overcome the complex barriers to producing fully functional recombinant chimpanzee GYPB.